- Report
- October 2025
- 160 Pages
Global
From €2827EUR$3,160USD£2,422GBP
€3534EUR$3,950USD£3,027GBP
- Report
- August 2026
- 160 Pages
Global
From €2970EUR$3,320USD£2,545GBP
€3712EUR$4,150USD£3,181GBP
- Report
- August 2026
- 160 Pages
Global
From €2970EUR$3,320USD£2,545GBP
€3712EUR$4,150USD£3,181GBP
- Report
- July 2026
- 160 Pages
Global
From €2970EUR$3,320USD£2,545GBP
€3712EUR$4,150USD£3,181GBP
- Report
- July 2026
- 130 Pages
Global
From €4339EUR$4,850USD£3,717GBP
- Report
- February 2026
- 89 Pages
Global
From €3500EUR$4,191USD£3,104GBP
- Report
- February 2026
- 170 Pages
Global
From €4339EUR$4,850USD£3,717GBP
- Report
- March 2026
- 135 Pages
Global
From €4339EUR$4,850USD£3,717GBP
- Report
- January 2026
- 190 Pages
Global
From €4428EUR$4,950USD£3,794GBP
- Report
- January 2026
- 97 Pages
Global
From €3086EUR$3,450USD£2,644GBP
- Report
- January 2026
- 187 Pages
Global
From €4160EUR$4,650USD£3,564GBP
- Report
- November 2025
Global
From €6709EUR$7,500USD£5,748GBP
- Report
- November 2025
- 52 Pages
Global
From €6709EUR$7,500USD£5,748GBP
- Report
- October 2025
- 85 Pages
Global
From €4026EUR$4,500USD£3,449GBP
- Report
- August 2026
- 70 Pages
Europe
From €4249EUR$4,750USD£3,641GBP
- Report
- August 2026
- 70 Pages
Asia Pacific
From €4249EUR$4,750USD£3,641GBP
- Report
- July 2026
- 70 Pages
Middle East, Africa
From €4249EUR$4,750USD£3,641GBP
- Report
- July 2026
- 80 Pages
Europe
From €4249EUR$4,750USD£3,641GBP
- Report
- February 2026
- 150 Pages
United States
From €2683EUR$2,999USD£2,299GBP
€3577EUR$3,999USD£3,065GBP
- Report
- July 2026
- 150 Pages
North America
From €4249EUR$4,750USD£3,641GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more